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Human  Cdc25C is a  protein  phosphatase  that  dephos- 
phorylates  and activates Cdc2-cyclin B to trigger  entry 
into mitosis. Cdc25C is itself regulated  by  phosphoryla- 
tion. In asynchronously growing HeLa cells, we have 
determined  that serine 216 is the major site of  Cdc25C 
phosphorylation. We have isolated a  protein kinase that 
binds to Cdc25C and  phosphorylates serine 216. “he ki- 
nase binds within amino acids 20&256  of  Cdc25C.  This 
region is conserved in some  Cdc25 homologues  and con- 
tains a  putative  bipartite  nuclear  localization  signal just 
downstream  from serine 216.  Finally, the Cdc25C-asso- 
ciating kinase was  purified  over  8000-fold from  rat liver 
as a  36-38-kDa  doublet of proteins. 
Progression  through  the  eukaryotic cell cycle involves the 
sequential  activation of cyclin-dependent kinases (Cdks)’ (re- 
viewed in Refs. 1 and 2). As the  name  implies,  activation of a 
Cdk is  dependent upon its association with a cyclin regulatory 
subunit. Cdk-cyclin complexes can also be regulated by revers- 
ible phosphorylation, which helps  to  ensure  the proper timing 
of activation  during  the cell cycle (reviewed in Ref. 3).  Entry of 
cells into mitosis is regulated in part by the activity of the 
Cdc2-cyclin B complex, which serves  as a paradigm for the  Cdk 
family. Cyclin B is  synthesized  and  associates  with Cdc2 in  the 
cytoplasm  beginning in  S-phase  and  continuing  throughout G,- 
phase (4). In  higher  eukaryotic cells, cyclin B association in- 
duces the  rapid phosphorylation of Cdc2 on  three  sites. Phos- 
phorylation on threonine 161 is required for kinase activity, 
whereas phosphorylation  on threonine  14  and  tyrosine 15 sup- 
presses  kinase  activity (5-12). I t  is the phosphorylation of thre- 
onine  14  and  tyrosine  15 that maintains Cdc2-cyclin B in  an 
inactive  state.  The  kinase r sponsible  for phosphorylating  thre- 
onine 14  has  not  been identified, but two kinases,  Weel  and 
Mikl,  have been  identified that regulate  the phosphorylation of 
tyrosine 15 (7-9, 13-15). Dephosphorylation of threonine 14 
and  tyrosine 15 is  the  final  step  in  the  activation of Cdc2-cyclin 
B and  is  required for entry of cells into mitosis (6, 11, 16,  17). 
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Dephosphorylation and activation of Cdc2-cyclin B is de- 
pendent upon the Cdc25 phosphatase. Cdc25 was  first  identi- 
fied as a cell cycle mutant  in Schizosaccharomyces  pombe that 
acts antagonistically to  Weel (18, 19). Homologues of Cdc25 
have  been  reported in several  other  eukaryotes,  including  three 
in  humans (denoted A, B, and C)  (20, 21). Cdc25 proteins  have 
a  conserved  carboxyl-terminal  domain that  has  limited homol- 
ogy to phosphotyrosine-specific protein  phosphatases (22). The 
homology region  includes the  “signature” motif (HCXXXXXR, 
where X represents  any  amino acid) that is conserved among 
the active sites of phosphotyrosine-specific protein  phosphata- 
ses. Cdc25 proteins possess intrinsic  phosphatase activity to- 
ward  tyrosine 15-phosphorylated Cdc2 complexed with cyclin B 
(23-27). Cdc25 will also dephosphorylate threonine 14- and 
tyrosine 15-phosphorylated Cdk2 complexed with cyclin A (28). 
Furthermore, mutation of the cysteine residue within the 
signature motif of Cdc25 abolishes its phosphatase activity 
(23-25). 
The Cdc25C protein  is  present  throughout  the cell cycle in 
higher  eukaryotes,  whereas its substrate (Cdc2-cyclin B) accu- 
mulates  throughout  the S-  and G,-phases of the cell cycle (20, 
29, 30). The  interesting  question  arises  as  to how Cdc25C and 
Cdc2-cyclin B are  prevented from  functionally interacting  until 
the  appropriate  time  in  the cell cycle. Cyclin B is synthesized 
during  S-phase  and  accumulates  in  the cytoplasm in a complex 
with Cdc2 (4). As HeLa cells (4)  and  starfish oocytes (31)  enter 
mitosis, Cdc2-cyclin B complexes enter  the nucleus.  Although 
Cdc2-cyclin B becomes activated  in  the cytoplasm of starfish 
oocytes (31, 32)  and Xenopus oocytes (33, 34), it is less  clear 
where Cdc2-cyclin B becomes activated  in  mammalian  tissue 
culture cells. Consistent with the  activation of Cdc2-cyclin B in 
the cytoplasm ofXenopus oocytes, it has been  found that Xeno- 
pus  Cdc25 is exclusively localized in  the cytoplasm (35). The 
subcellular localization of Cdc25C in  mammalian  tissue  culture 
cells is less clear. In  rat  and  human  fibroblasts  (29)  and  HeLa 
cells (201, endogenous Cdc25C has been  found in  the  nucleus 
during  interphase.  Other  reports  suggest  that Cdc25C is local- 
ized in  the cytoplasm in  hamster cells (36) or when human 
Cdc25C is overexpressed in  HeLa or baby hamster  kidney cells 
(37).’A number of Cdc25 proteins  contain a  region with homol- 
ogy to  bipartite  nuclear localization  signals. There  are a num- 
ber of potential phosphorylation sites  near  the  putative  nuclear 
localization signal,  suggesting  the possibility that  the subcel- 
lular localization, and  therefore  interaction  with Cdc2-cyclin B, 
may be  controlled by phosphorylation. 
Phosphorylation  has  been found to directly activate  the  en- 
zymatic activity of Cdc25C (35,  38-40). Cdc25C becomes phos- 
phorylated  and  activated as cells progress into “phase (35,38, 
40-43).  Studies  have  suggested that Cdc2-cyclin B phosphoryl- 
ates  and  activates Cdc25C leading  to an “autoactivation loop” 
L.  Paige and H.  Piwnica-Worms,  unpublished  observation. 
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(39, 40, 44). However, other  studies  suggest the existence of 
other  kinases that phosphorylate  and  activate Cdc25 proteins 
(35, 39). To understand  the  regulation of Cdc25C, it is impor- 
tant to  identify  phosphorylation sites of Cdc25C in vivo and  to 
identify  the responsible kinases. 
In this study, we identify serine 216 as the major phospho- 
rylation  site  in Cdc25C isolated from  asynchronously  growing 
HeLa cells. In  addition, we report  the purification of a protein 
kinase from rat liver that phosphorylates Cdc25C in vitro on 
serine 216. Interestingly,  this  kinase  not only phosphorylates 
Cdc25C, but  it  also  binds  to a region  (bordered by amino acids 
200-256) located within  the  amino  terminus of Cdc25C. This 
binding region of Cdc25C contains a putative  bipartite  nuclear 
localization  sequence  positioned just  downstream of serine 216 
and is conserved among  several Cdc25 family  members. 
EXPERIMENTAL PROCEDURES 
Tissue Culture and 32P Labeling of  Cdc25C-HeLa cells  were  grown 
in Dulbecco's  modified Eagle's  medium supplemented with 2 mM gluta- 
mine and 10% fetal calf serum. HeLa  cells  were 32P-labeled as follows. 
Cells were grown to approximately 80% confluence on 10-cm2 tissue 
culture dishes. Cells were washed with prewarmed phosphate-free 
Dulbecco's  modified Eagle's medium. Cells  were labeled for 3  h at 37  "C 
in 1.5  ml of phosphate-free Dulbecco's  modified Eagle's  medium supple- 
mented with 2 mCi/ml 32P-labeled inorganic phosphate, 2 mM gluta- 
mine, and 10% dialyzed calf serum. Labeled cells were washed with 
phosphate-buffered saline (137 mM NaCI,  2.7 mM KCl, 4.3 mM 
Na2HP0,.7H,0, 1.4 mM KH,PO,, pH 7.3) and lysed in 1.2 ml  of  NETN 
buffer  (20 mM Tris, pH 8.0, 0.5% Nonidet  P-40, 1 mM EDTA, 100 mM 
NaCU adjusted to 1 M NaCl and supplemented with 2 mM phenylmeth- 
ylsulfonyl fluoride, 0.15 unitdml aprotinin, 20 p~ leupeptin, 20 p~ 
pepstatin, 5 p~ microcystin, 10 m~ NaF, and 0.5 mM sodium vanadate. 
The cell lysates were  clarified by centrifugation at 10,000 x g  for 15 min. 
Lysates were precleared with 100 p1 of Sepharose CL-4B protein A 
beads. Immunoprecipitation reactions were  performed using 10 pg of 
either nonimmune IgG or antibody purified to the amino-terminal 258 
amino acids of human Cdc25C. Antibody-antigen complexes  were puri- 
fied with 20 pl of Sepharose CL-4B protein A beads and washing 3 times 
with radioimmune precipitation buffer (20 mM Tris, pH 7.4, 137 mM 
NaCl, 10% glycerol, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton 
X-100, 2 mM EDTA), 2 times in NETN buffer, and once more with 
radioimmune precipitation buffer (each supplemented as described 
above). Proteins were released from the beads by boiling in 100  pl of 1% 
SDS in phosphate-buffered saline for 5 min. The beads were pelleted 
and the  supernatant diluted into 900 pl of NETN  buffer.  Cdc25C was 
reimmunoprecipitated using this same protocol and solubilized  from the 
beads in SDS sample buffer by boiling  for 5 min. 
Affinity Purification of Cdc25C(N258) Antibody-GST and GST- 
25(N258) (27) were  coupled  to activated CH-Sepharose 4B (Pharmacia 
Biotech  Inc.)  according to the manufacturer's instructions. Polyclonal 
GST-25C antisera were passed over a GST-Sepharose  column  to  remove 
antibodies specific  for  GST. Unbound antisera were  loaded  onto a GST- 
25(N258)-Sepharose column.  Nonspecific antibodies were  removed by 
washing with radioimmune precipitation buffer, and then NETN  buffer 
was adjusted to 1 M NaC1. Antibodies specific for Cdc2XN258) were 
eluted first with 100 mM glycine (pH 2.5) and then with 1% triethyl- 
amine (pH 11). All fractions were neutralized with 1 M Tris (pH 8.0). 
Bovine serum albumin was added to a final concentration of 0.1 mg/ml 
to each fraction containing antibody. Proteins were precipitated with 
50% ammonium sulfate (wh) and centrifugation. Samples were resus- 
pended in Tris-buffered saline (10 m~ Tris, pH 8.0,0.5 M NaCl) and  then 
dialyzed against Tris-buffered saline. 
Purification of GST Fusion Proteins-Expression and purification of 
GST fusion proteins were  accomplished essentially as described (27). 
Routinely,  100 ml  of overnight culture was used to inoculate 1 liter of 
Luna broth. After a 1-h incubation at 37  "C, isopropyl-P-D-thiogalacto- 
pyranoside was added to a final concentration of 0.5 m. Following a 2-h 
incubation at room temperature,  the cells  were  collected by centrifuga- 
tion at 3800 x g for  10  min. The cells  were resuspended in phosphate- 
buffered saline, aliquoted, and then recentrifuged at 5000 x g. Each 
aliquot represented 20 ml of bacterial culture. Bacterial pellets were 
stored at -80 "C until use. For use, each frozen bacterial pellet was 
resuspended in 5 ml of NETN  buffer supplemented as described  above 
and containing 0.5 mg/ml  lysozyme. The suspensions were incubated at 
4 "C for 10 min and sonicated 10 times for 1 s each using a probe tip 
sonicator at  its maximum setting. The sonicates were centrifuged at 
12,000 x g for 10 min. The clarified supernatants were incubated with 
glutathione (GSH)-agarose beads at 4 "C  for  30 min. The beads were 
then washed 4 times with NETN buffer. Purification of insect cell- 
produced GST fusion proteins was performed as described (12). 
Cdc25-associating Kinase Assays-2-20 pg of bacterially produced 
GST fusion proteins were purified on 15 pl of GSH-agarose as described 
above. The beads were  rocked with either 0.1 mg of HeLa  cell lysate or 
column fractions diluted into 0.5 ml  of  NETN buffer  for 1-2 h at 4 "C. 
The beads were pelleted and washed twice with 0.7 ml of NETN  buffer 
and twice with 0.5 ml of kinase wash buffer (KWB; 50 m Tris, pH  7.4, 
10 mM MgCl,). The beads were pelleted, and reactions were carried out 
in 25  pl of KWB containing 2 m dithiothreitol, 20 p~ ATP, and 10 pCi 
of  [y-32PlATP (>4000Ci/mmol). In some experiments, soluble substrates 
were  also added. After a 5-min incubation at 30 "C, the reaction was 
terminated by the addition of  20 p1 of 3  x SDS sample buffer and boiling 
for 5 min.  After electrophoresis on  SDS-polyacrylamide  gels, the pro- 
teins were visualized by staining with Coomassie Brilliant Blue and 
autoradiography. Radioactivity incorporated into protein bands was 
quantitated by excising the band and Cerenkov  counting. 
Phosphopeptide Mapping and Phosphoamino Acid  Analysis--Tryptic 
digests were  performed essentially as described (45). Digested peptides 
were  resolved by electrophoresis in the  first dimension and ascending 
chromatography in the second as described (7). Two-dimensional  phos- 
phoamino  acid analysis was performed as described (7). 
Sequencing of Cdc25C Phosphorylation Site-75 pg of GST-25(N258) 
was purified from bacteria using 100 pl of GSH-agarose beads as de- 
scribed. l ml of rat liver PlOO (see below)  was  solubilized in 10 ml of 
NETN  buffer  for  10 min and clarified at 10,000 x g for 10 min. The 
supernatant was incubated with the immobilized  GST-25(N258)  for 2 h. 
After 5 washes with NETN  buffer and 3 washes with KWB, the beads 
were incubated in KWB containing 2 mM dithiothreitol, 0.5 p~ ATP, and 
10 pCi of [Y-~~PIATP for 30 min at  30 "C. The reaction was stopped by 
addition of 3  x SDS sample buffer and boiling  for 5 min.  GST-25(N258) 
was  resolved  from the unincorporated radioactivity using an SDS-poly- 
acrylamide gel.  GST-25(N258) was excised and incubated in 5 ml of 30% 
methanol at 37  "C, changing into fresh methanol 4 times over a 24-h 
period. The gel  slice was then  treated with 0.5 mg  of sequencing grade 
trypsin (Sigma) in  4 mg/ml  ammonium bicarbonate for several hours at 
37  "C. Fresh trypsin was added, and the digestion was allowed  to  con- 
tinue overnight. Peptides released from the gel slice were stored at  
-80  "C. The gel  slice  was treated with fresh trypsin solution once more. 
Released peptides were pooled and dried in vacuo. Peptides were then 
washed with decreasing volumes of water (100, 100,50,  and 25 pl)  and 
dried in uacuo. 
Washed peptides were separated using a Hewlett Packard 1090 high 
pressure liquid chromatography system with a Vydac 2.1-mm  C18 re- 
verse phase column. Fractions were Cerenkov  counted  to identify phos- 
phorylated peptides. One quarter of the major phosphopeptide was 
subjected to automated Edman degradation and analysis using an Ap- 
plied  Biosystems  477 protein sequencer and Applied  Biosystems  120. 
The rest of the phosphopeptide was subjected  to semi-automated amino- 
terminal sequence analysis using a Beckman 890C spinning cup se- 
quencer (46). 
Construction of GS2"25(20&256)-Sequences encoding  amino acids 
200-256 of Cdc25C  were amplified by polymerase chain reaction using 
pGC52(cdc25Hs) as the template (27). The primers were as follows: 
NH2-terminal, 5'-GGCAGATCTCCGGATCCAAAGATCMGAAGCAA- 
AGG-3' (contains BglII and BamHI sites); carboxyl-terminal, 5'- 
GGGAA?TCGTCGACCTATAAGCCC'I"I'CCTGAGCTITCC-3' (contains 
EcoRI and Sal1 sites). The polymerase chain reaction product was di- 
gested to completion with BgZII and EcoRI and was  cloned into BamHY 
EcoRI-linearized pGEX-3X. 
Construction of pGEX-2TN25CHamster-pET3a-hamster Cdc25C 
was digested with NdeI and XmaI. The insert encoding full-length ham- 
ster Cdc25C was ligated into the NdeIIXmaI site of pGEX-2TN to  gen- 
erate pGEX-2TN25CHamster. 
Purification of Cdc25C-associating Kinase from Rat Liver-The en- 
tire purification was done at 4 "C or on  ice. 100 g of frozen rat livers 
(Pel-Freez Biologicals,  Rogers, A R )  were  homogenized using a Waring 
blender in 200 ml of 20 mM Hepes,  pH  7.6,  100 m~ NaC1, 1 mM dithio- 
threitol, 1 mM EGTA, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 
20 p~  pepstatin, 20 p~ leupeptin. The homogenate  was  clarified using 
successive centrifugation spins at 1000 x g for  10  min, 10 x kg  for  20 
min, and twice at 100 x kg for 1 h each. The 100 x kg pellet (P100) 
contained some  Cdc25C-associating kinase activity and was used for 
certain experiments. The supernatant (5100) was passed through 0.8- 
micron and  then 0.45-micron  Nalgene syringe filters. The sample was 
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loaded  onto  a 60-ml S-Sepharose Fast Flow column  (Pharmacia)  equili- 
brated  in  buffer  A  (20 mM Hepes, pH 7.0, 1 mM EGTA, 1 mM EDTA) 
containing 0.1 M NaCI. After  washing  with  buffer  A  containing  0.1 M 
NaCI, bound proteins  were  eluted  with a 100-ml linear  gradient of NaCl 
(0.1-0.6 M). 5-ml fractions  were collected and  assayed  for Cdc25C-asso- 
ciating kinase activity with GST-25(200-256) as  the affinity reagent 
and  kinase  substrate.  Fractions  with  the  highest  Cdc25C-associating 
kinase  activity  were pooled and  buffer  exchanged  into  buffer B (10 mM 
Tris, pH 8.0, 0.05% Brij-35) containing 20 mM NaCl using a 190-ml 
Sephadex G-25 column  (Pharmacia).  Appropriate  fractions  were pooled 
and loaded onto  a 25-ml Q-Sepharose  column  (Pharmacia)  pre-equili- 
brated  in  buffer B containing  20 mM NaC1. Proteins  were  eluted  with  a 
120-ml linear  gradient of NaCl (20-320 mM). 5-ml fractions  were col- 
lected and  assayed  under  standard  conditions.  The  peak  fractions  were 
pooled and  diluted  with  buffer B to  reduce  the  NaCl  concentration  to 0.1 
M. This  material  was loaded onto a 5-ml ATP-agarose column  (Sigma, 
A-6888) equilibrated  in  buffer  B  containing 0.1 M NaCI. After  extensive 
washing,  the  bound  proteins  were  eluted  in  buffer B containing 0.8 M 
NaCI. Eluted proteins were buffer exchanged into buffer C (20 mM 
Hepes, pH 7.6, 1 mM EGTA, 1 mM EDTA,  0.05% Brij-35)  containing  50 
mM NaCl  using  the  Sephadex G-25 column described above. Appropri- 
ate fractions were pooled and loaded onto a 1-ml Resource S column 
(Pharmacia).  Proteins  were  eluted  with  a 5-ml linear  gradient of NaCl 
(50-300 mM). 0.5-ml fractions  were collected and  assayed  under  stand- 
ard conditions.  Fractions  with  Cdc25C-associating  kinase  activity  were 
pooled and  concentrated  to 0.7 ml using a Centricon-10 concentrator 
(Amicon). 0.5 ml was  loaded  onto a Superose-12 10/30 column  (Phar- 
macia)  in  buffer  C  plus  50 mM NaCI. 0.5-ml fractions  were collected and 
assayed  under  standard  conditions.  Molecular  weight  standards  were 
run on the Superose-12 10/30 column a t  a concentration of approxi- 
mately 1 mg/ml using  the  same  buffer  conditions  (bovine  serum  albu- 
min,  66 m a ;  carbonic  anhydrase, 29 kDa; cytochrome c, 12.4 kDa). 
In Gel Kinase Assays-In gel kinase  assays  were  performed  essen- 
tially as  described  (47).  Samples  were resolved on SDS-polyacrylamide 
gels that  had been polymerized in  the  absence or presence of 0.1 mg/ml 
GST-25 (200-256). After  electrophoresis, the gels  were  washed  twice  in 
100 ml of 20% isopropanol,  50 mM Tris, pH 8.0 (v/v), for 1 h. The  gels 
were  then  washed  in  100 ml of 50 mM Tris, pH 8.0, 5 mM P-mercapto- 
ethanol for 1 h. The  proteins  were  denatured  with  two 100-ml washes  in 
6 M guanidine HCI, 50 mM Tris, pH 8.0, 5 mM P-mercaptoethanol  for 1 h 
each.  The  proteins  were  renatured a t  4 "C using  several 250-ml washes 
with 50 mM Tris, pH 8.0,5 mM P-mercaptoethanol, 0.04% Tween-20 over 
a 16-h period. The  gels  were  then  incubated for 30  min at room tem- 
perature in renaturation kinase buffer (50 mM Hepes, pH 7.6, 1 mM 
dithiothreitol, 0.1 mM EGTA, 3 mM magnesium  acetate, 0.01% Nonidet 
P-40). Kinase assays were performed in renaturation kinase buffer 
containing 20 p~ ATP and 40 pCi/ml [y-"PIATP. After 1 h at room 
temperature,  the  kinase  assays  were  terminated  with 5% trichloroace- 
tic acid, 1% sodium pyrophosphate in water (w/w/v). Unincorporated 
radioactivity was washed away in the same solution using several 
changes over a 16-h period. The  gels  were  rinsed  with  water,  dried,  and 
subjected  to  autoradiography. 
RESULTS 
Phosphorylation  State of Cdc25C from Asynchronously 
Growing HeLa Cells-The phosphorylation state of human 
Cdc25C was  examined by immunoprecipitation of Cdc25C from 
32P-labeled HeLa cells. Cdc25C was  immunoprecipitated  using 
antibodies affinity  purified against its amino-terminal 258 
amino  acids,  released by boiling in 1% SDS, and  then re-im- 
munoprecipitated. A phosphoprotein with an  apparent molec- 
ular  mass of 55-57 kDa  was specifically immunoprecipitated 
with anti-Cdc25C antibodies (Fig. L4, lane 2)  but not with 
control antibodies  (Fig. LA, lane 1). Cdc25C was  eluted from the 
gel and subjected to tryptic digestion and two-dimensional 
analysis  as well as  to phosphoamino  acid analysis.  One  major 
phosphopeptide was detected  (Fig. 1B 1, and phosphoamino  acid 
analysis revealed  phosphoserine  (Fig. 1C). 
Association of Cdc25C  with a Protein Kinase in Vitro-We 
tested if the  kinase responsible for phosphorylating Cdc25C in 
vivo would stably bind to Cdc25C in vitro (Fig. 2). GST, GST- 
25C, GST-25(N258), and GST-25(C215) were purified on GSH- 
agarose beads (Fig. 2 A ) .  Immobilized GST,  GST-25C,  GST- 
25(N258), and GST-25(C215) were incubated with HeLa cell 
A 1 2  B 
200 kDa - 
100 kDa - 
68 kDa - 
* -  
C 
43 kDa - 
21 kDa . 
FIG. 1. Analysis of Cdc25C immunoprecipitated from asyn- 
chronously growing HeLa cells. Asynchronously growing  HeLa cells 
were '"P-labeled and lysed as  described under "Experimental Proce- 
dures."  Either  preimmune  antibody  (lane 1 )  or anti-Cdc25C(N258)  an- 
tibody (lane 2) was used for an immunoprecipitation reaction, and 
samples were resolved using a 10% SDS-polyacrylamide gel. "P-La- 
beled proteins  were  visualized by autoradiography  (panel A) .  Cdc25C 
was  eluted from the gel,  and  portions  were  subjected  to  either  tryptic 
digestion and two-dimensional analysis (panel B )  or phosphoamino 
acid analysis  (panel C). 
extracts,  washed,  and  assayed for kinase activity either  in  the 
absence of added  substrate (Fig. 2B, lanes 1 ) or  in  the presence 
of soluble GST (Fig. 2B, lanes 2) or GST-25C (Fig. 2B, lanes 3) .  
A protein kinase  activity  was detected that bound to and phos- 
phorylated  both GST-25C and GST-25(N258). Neither GST nor 
GST-25(C215) bound the  kinase.  This  experiment localized the 
kinase  binding  site  and  the phosphorylation site  to  within  the 
first 258 amino  acids of Cdc25C. The enhanced  phosphorylation 
of GST-25(N258) compared with GST-25C was not routinely 
observed in  all  experiments  (see Fig. 6). 
Two-dimensional tryptic phosphopeptide mapping of GST- 
25C phosphorylated in vitro by the associating kinase revealed 
a single phosphopeptide (Fig. 2C), and phosphoamino acid 
analysis revealed phosphoserine (Fig. 2 0 ) .  Using this assay, 
Cdc25C-associating kinase activity has been  detected in  other 
human cell lines, Xenopus egg extracts," and rat liver (see 
below). 
Serine 216 Is Phosphorylated by the  Cdc25C-associating 
Kinase-To identify the  serine  in Cdc25C that  was phosphoryl- 
ated by the  associating  kinase, GST-2XN258) was used as  an 
affinity reagent  and  substrate for the associating kinase.  The 
PlOO fraction from rat  liver (see below) was used as  the source 
of kinase. "P-labeled GST-25(N258) was digested  with trypsin, 
and  the  resulting  peptides were  purified by HPLC. Phospho- 
rylated species  were  identified by Cerenkov  counting.  One ma- 
jor (15,000 cpm) and three minor (2900, 700, and 200 cpm) 
radioactive peaks were  identified. These different peaks were 
taken  to be different  oxidative states of the  same phosphopep- 
tide andor incomplete tryptic digestion  products  because  per- 
formic acid treatment  (omitted  in  this  experiment)  and com- 
plete  tryptic digestion of either GST-25C or GST-25(N258) gives 
rise  to a single  phosphopeptide (see Fig. 2 0 .  The major  peak 
was divided and used for different methods of amino-terminal 
sequence analysis. The sequence of the phosphopeptide was 
determined by automated  Edman  degradation  using poly- 
brene-coated glass fiber  discs  (Fig. 3). Although the  site of phos- 
phorylation could be inferred by the lack of serine  in 
S. Ogg and H. Piwnica-Worms, unpublished  observations. 
30464 Purification of a Cdc25C"associating Kinase 
A GST CST-25C GST-Zj(N258) CST-Zj(CZI3 
1 2 3   1 2 3   1 2 3   1 2 3  
B GST CST-ZX GST-ZHN258)  CST-Z (C215) 
1 2 3   1 2 3   1 2 3   1 2 3  
w - -c 
CST-2X - - .  
0 
CST - 
C 
~. ,,-... 
D 
lysate was incubated with GST, GST-25C, GST-25(N258), or GST- 
FIG. 2. Binding of a cellular protein kinase to Cdc25C. HeLa cell 
25(C215) that  was immobilized on GSH-agarose  beads.  The  beads  were 
washed  and divided into  three,  and  kinase  assays  were  performed  in  the 
presence of buffer only (lanes 1 )  or  2  pg of soluble GST (lanes 2) or 
GST-25C (lanes 3) .  Proteins  were resolved on an 11% SDS-polyacryl- 
amide gel. Proteins  were  visualized by Coomassie staining (panel A )  
cycle 8, this method  does not allow for positive identification of 
phosphoserine. The phosphorylation site  was  determined more 
directly using  semi-automated  amino-terminal sequence anal- 
ysis. The radioactivity released  in each cycle was  determined 
by Cerenkov counting (Fig. 3). Consistent  with phosphorylation 
a t  serine  in cycle 8, the radioactivity was released in cycle 8. 
These  data  demonstrated that Cdc25C was phosphorylated on 
serine 216 by the  associating  kinase  in vitro. 
Cdc25C Is Phosphorylated on Serine 216 in Vivo-The tryptic 
peptide of Cdc25C that  contains  serine 216 has  an  additional 
serine at position 214. I t   has been reported  that Cdc25C can be 
phosphorylated on serine 214 in vitro by Cdc2-cyclin B and  that 
the  tryptic peptide containing  serine 214 is phosphorylated in 
mitotic cells. Since serine 214 and  serine 216 are  within  the 
same  tryptic  peptide  it  was necessary to  determine if the major 
site of phosphorylation in Cdc25C from asynchronously grow- 
ing HeLa cells was serine 214 or serine 216. To determine 
whether peptide phosphorylated on serine 214 could be re- 
solved from peptide  phosphorylated on serine 216, two-dimen- 
sional tryptic phosphopeptide mapping  was performed. 
To generate peptide containing phosphorylated serine 216, 
GST-25(200-256) was phosphorylated in vitro using Cdc25C- 
associating  kinase purified from rat  liver followed by tryptic 
digestion (Fig. 4 A ;  see below). To generate peptide  containing 
phosphorylated serine 214, GST-25(200-256) was phosphoryl- 
ated  in vitro using Cdc2-cyclin B followed  by tryptic digestion 
(Fig. 4B). Although the  site of phosphorylation has  not been 
directly  sequenced, serine 214 is  the only serine/proline motif 
found within amino acids 200-256 of Cdc25C. We have also 
found that Cdc2-cyclin B  can  phosphorylate  a  peptide  contain- 
ing  serine 214 but  cannot phosphorylate the corresponding pep- 
tide  in which serine 214 has been  changed to  alanine.3  In  ad- 
dition,  serine 214 was previously shown to be a substrate of 
Cdc2-cyclin B in vitro (44). As seen in Fig. 4C, a mixture of 
tryptic  peptides phosphorylated on either  serine 214 or serine 
216 was resolved in two dimensions under  the conditions em- 
ployed in this study. Serine 216-phosphorylated peptide mi- 
grated faster in the second dimension than did serine 214- 
phosphorylated  peptide. Peptides phosphorylated a t  either 
serine 214 or 216 could also be distinguished by secondary 
digestion with  aminopeptidase M."  To determine  whether 
Cdc25C from asynchronously  growing  HeLa cells was phospho- 
rylated on serine 214 or serine 216, tryptic phosphopeptide 
mapping  studies were  performed on GST-25C phosphorylated 
on serine 216 by the  associating  kinase  in vitro (Fig. 4 0 )  and 
Cdc25C isolated from "P-labeled HeLa cells (Fig. 4E). A mix- 
ture of these two tryptic digestions demonstrated  that  the pep- 
tides comigrated in two dimensions  (Fig. 4F).  These  data dem- 
onstrated  that Cdc25C was phosphorylated on serine 216 in 
asynchronously  growing  HeLa cells. 
Serine 216 Is Present within a Region That Is Conserved 
among  Several Cdc25 Family Members-Although the amino- 
terminal, non-catalytic portion of Cdc25 proteins  is  less well 
conserved than  the  catalytic  half,  there  are noted regions of 
homology. Serine 216  lies within one of these regions. As dem- 
onstrated  in Fig. 5, amino acids located between 200 and 256 of 
human Cdc25C are conserved among a number of Cdc25 pro- 
teins  including  human Cdc25A and Cdc25B, rat  A and B, mouse 
M2, and Xenopus 1, 2, and 3. This region is notably  lacking in 
the  hamster Cdc25C and mouse M1  proteins, which have most 
similarity to human Cdc25C. Within this region is a stretch of 
" B. Gabrielli  and  H. Piwnica-Worms, unpublished data. 
and  autoradiography (panel B ) .  Phosphorylated GST-25C was  eluted 
from the gel and subjected to either  tryptic  digestion  and two-dimen- 
sional  analysis (panel C )  or  phosphoamino acid analysis (panel D). 
FIG. 3. Serine 216 of Cdc25C is phos- 
phorylated by the Cdc25C-associat- 
ing kinase. GST-25(N258) was used as  
both  affinity  reagent  and  substrate for an 
associating kinase assay. GST-25(N258) 
beled peptides were purified by HPLC. 
was digested with trypsin, and radiola- 
The amino acid sequence of the major 
phosphopeptide was determined by mi- 
crosequencing. The position of the phos- 
phorylation was determined by monitor- 
ing  the  radioactivity  released  in  each 
cycle. The  sequence of the  peptide  and po- 
sition of the phosphorylation (cycle 8, ser- 
ine  216) are shown  compared  with the se- 
quence of human Cdc25C. 
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FIG. 4. The major tryptic phosphopeptide of Cdc25C from 
HeLa cells comigrates with the tryptic phosphopeptide contain- 
ing phosphorylated serine 216 of Cdc25C. Tryptic  digestions  and 
two-dimensional analyses were performed on GST-25(200-256) phos- 
phorylated in vitro by Cdc25C-associating  kinase  purified from rat liver 
(panel A),  GST-25(200-256) phosphorylated in vitro by Cdc2-cyclin B 
(panel B ) ,  GST-25C phosphorylated in vitro by the Cdc25C-associating 
kinase from HeLa cells (panel D), or Cdc25C from radiolabeled  HeLa 
cells (panel E ) .  Mixtures of these  tryptic  digestions  were  separated  in 
two dimensions to demonstrate the relative migration of the phos- 
phopeptides. Panel C ,  mixture  ofA  and B; panel F, mixture of D and E. 
amino acids that  has homology to  bipartite  nuclear localization 
signals. 
Amino Acids 200-256 of Cdc25CAre  Sufficient for Binding to 
the Associating Kinase-We determined  whether  amino acids 
surrounding  serine 216 (amino acids 200-256) were  sufficient 
for binding to  the Cdc25C-associating kinase (Fig.  6). HeLa cell 
extracts were incubated with GST, GST-25C, GST-25(N258), 
GST-25(C215), GST-25(200-256), or GST-25(Hamster) immobi- 
lized on GSH-agarose beads. After washing, the beads were 
G L Y R S P S M P E N L R P R L K Q V  
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divided and assayed for kinase activity  toward GST or GST- 
25(200-256). A  protein kinase activity  was  detected that bound 
to GST-232, GST-25(N258), and GST-25(200-256) but not to 
GST, GST-25(C215), or GST-B5(Hamster). This  kinase activity 
phosphorylated GST-25(200-256) but was unable  to phospho- 
rylate GST. These results indicated that amino  acids 200-256 
of human Cdc25C are sufficient to  bind to  the associating ki- 
nase. Furthermore, hamster Cdc25C, which lacks  a corre- 
sponding  region,  was  unable to bind Cdc25C-associating kinase 
activity. 
Purification of a Cdc25C-associating Kinase from Rat 
Liver-The Cdc25C-associating kinase phosphorylated Cdc25C 
in vitro at  the major site of phosphorylation detected in vivo 
and showed interesting binding  properties,  suggesting that  it 
may function as an important Cdc25C regulator in vivo. To 
study the interactions between Cdc25C and the associating 
kinase, we purified the kinase. After homogenization and clar- 
ification of rat  livers, 50-80% of Cdc25C-associating kinase 
activity was associated  with the 100 x kg supernatant  6100) 
fraction with  the  remainder  in  the p llet  (P100). The solubility 
of kinase activity was dependent upon the concentration of 
NaCl since higher NaCl concentrations led to more activity 
partitioning  in  the SlOO fraction. The  kinase  was purified from 
the SlOO fraction using a number of chromatographic steps. 
Fractions from each step were assayed for kinase activity, 
which would both bind to  and phosphorylate GST-25(200-256). 
The SlOO fraction was chromatographed on an S-Sepharose 
column a t  pH 7.0 using a linear  gradient of NaCl. The peak of 
activity eluted a t  approximately 340 mM NaCl and was purified 
over 50-fold. To maintain soluble kinase activity, it  was neces- 
sary to include 0.05% Brij-35 in all buffers for the  remaining 
steps of the purification. The peak of kinase activity from the 
S-Sepharose column was buffer exchanged before being puri- 
fied a further 5-fold  on a Q-Sepharose column. At  pH 8.0, the 
peak of kinase activity eluted from the Q-Sepharose column a t  
approximately  130 mM NaCl, with  variable minor peaks of ac- 
tivity eluting a t  higher NaCl concentrations. These minor 
peaks of activity  were  not reproducible and may have repre- 
sented either modified (e.g. proteolytic fragments) or aggre- 
gated forms of the kinase. The major  peak of kinase activity 
was  chromatographed using  an ATP-agarose column and 
eluted with a step  gradient of 0.8 M NaCl. This  step provided a 
3.4-fold purification. The peak  fractions were buffer exchanged 
to pH 7.6 and chromatographed on a Resource S column. The 
peak of activity eluted a t  approximately 190 mM NaCl and was 
purified almost 2-fold. The peak fractions were concentrated 
and then separated using a Superose-12 10/30 gel filtration 
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Cdc25C 
Amino-terminal half (N258) Catalytic domain (C215) ine 216 of human Cdc25C is con- 
FIG. 5. The region surrounding ser- 
served in other Cdc25 proteins. A 
schematic of human Cdc25C illustrates 
the loosely conserved amino-terminal  258 
amino  acids  and  the  highly conserved 
catalytic  domain  that  contains  the  active 
site  (HCEFSSER).  The  sequence of amino 
acids 200-256 of human Cdc25C is 
aligned  with  other Cdc25 proteins.  Serine 
216 is  denoted by an asterisk. A putative 
bipartite  nuclear  localization  signal  is  in- 
dicated by the bars. GenBank accession 
numbers  are  as follows: Human C ,  
M34065; Swine, X78317; Hamster, 
S54051; Mouse M I ,  L16926; Human A, 
M81933; Rat A, D16236; Human R ,  
M81934; Mouse M 2 ,  S93521; Rat B ,  
D16237; Frog A, M96857; Frog I (B)? 
M94262(M96858); Frog 2, M94263; Frog 
3, M94264. 
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GST-  GST- teins were solubilized in  SDS  sample buffer by boiling. A por- 
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FIG. 6. Amino acids 200-256 of human Cdc25C are sufficient for 
binding to Cdc25C-associating kinase activity. HeLa cell lysate 
was  incubated  with GST, GST-25C. GST-25(N258), GST-25(C215), GST- 
25(200-256), or GST-25(Hamster)  that  was immobilized on GSH-agar- 
ose beads. The beads were washed and divided into two, and  kinase 
GST-25(200-256) (lanes 2) .  Proteins were resolved on an 11% SDS- 
assays  were  performed  in  the  presence of 2 pg of either  GST (lanes I ) or 
polyacrylamide gel. Proteins were visualized by Coomassie staining 
(panel A )  and  autoradiography (panel R) .  
column. The  peak of kinase  activity  eluted  with an  apparent 
molecular mass of approximately 30-40 kDa (Fig. 7A). The 
entire purification resulted in over an 8000-fold purification 
with  greater  than 3% yield (Table I). Column fractions from the 
Superose-12 10/30 column were resolved on an 11% SDS-poly- 
acrylamide gel and visualized by silver  staining  (Fig. 7B 1. Two 
proteins of approximately 36-38 kDa  coeluted with  the  peak of 
activity. Thus,  it  is likely that  one  or both of the  proteins a t  
-36-38 kDa  represented  the Cdc25C-associating kinase. 
If the 36-38-kDa proteins  are Cdc25C-associating kinases, 
then  they  should bind to  and  phosphorylate GST-25(200-256). 
Either buffer alone  (Fig. 8, lanes 1) or pooled fractions 17-19 
from the Superose-12 10/30 column (lanes 2 )  were incubated 
with immobilized GST or GST-25(200-256). After washing, pro- 
ide gel and visualized by silver staining (Fig. 8A).  Each  band of 
the 36-38-kDa doublet bound to GST-25(200-256) but  not to 
GST. No other  proteins from fractions 17-19 bound to  either 
GST or GST-25(200-256). Another  portion of each  sample  was 
used for an  in gel kinase assay. The  samples were resolved on 
an SDS-polyacrylamide gel that  had been polymerized in  the 
presence of GST-25(200-256). The  proteins were  subjected to 
an  in gel denaturation  and  renaturation protocol followed by a 
kinase assay. The gel was  washed,  and phosphorylated  proteins 
were visualized using  autoradiography of the  dried gel (Fig. 
8B). A protein  kinase activity was  present  in  fractions 17-19 
with an  apparent molecular mass of 36-38 kDa. This  kinase 
activity  bound to GST-25(200-256) but  not  to GST. The  kinase 
activity  was specific for Cdc25C since if GST was used as a 
substrate,  less  than 2% of the  kinase  activity  was d e t e ~ t e d . ~  
These experiments identified the 36-38-kDa doublet as the 
Cdc25C-associating kinase. 
DISCUSSION 
In  this study, we demonstrate  that  serine 216 is  the major 
site of Cdc25C phosphorylation in asynchronously growing 
HeLa cells. We describe a kinase that binds to Cdc25C and 
phosphorylates Cdc25C on serine 216. We have determined 
that amino  acids 200-256 of Cdc25C are sufficient for binding 
to  the  associating  kinase. Within this region is a putative bi- 
partite  nuclear localization signal  that  is positioned just down- 
stream of serine 216. In  addition, we purified  a Cdc25C-asso- 
ciating  kinase over 8000-fold and identified two proteins  with 
apparent molecular masses of 36 and 38 kDa that have 
Cdc25C-associating kinase activity. 
In a variety of species, Cdc25 proteins  are underphosphoryl- 
ated  during  interphase  and become hyperphosphorylated dur- 
ing "phase (35, 38 ,4043) .  This hyperphosphorylation corre- 
lates  with  the activation of Cdc25 enzymatic activity (35, 38- 
40). Cdc25 is a substrate of Cdc2-cyclin B in  vitro, and 
phosphorylation activates Cdc25 phosphatase activity  (39, 40, 
44).  Tryptic  phosphopeptide mapping revealed that  many of the 
same  peptides phosphorylated in vitro by Cdc2-cyclin B are also 
phosphorylated in  vivo (39, 44). This  has led to  the hypothesis 
that  a self-amplification loop exists  in which accumulation of 
active Cdc2-cyclin B causes  the phosphorylation and activation 
of Cdc25, which then  activates more Cdc2-cyclin B. This hy- 
pothesis would explain  the  abrupt  and  irreversible  nature of 
"phase and  the  ability of maturation-promoting factor to ac- 
tivate  prematuration-promoting factor in Xenopus oocytes (48, 
49). However, i t  still  remains  unclear  as  to  the  nature of the 
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FIG. 7. Cdc25C-associating kinase activity from rat liver copu- 
rifies with two proteins with apparent molecular masses of 36 
and 38 kDa. Cdc25C-associating kinase activity was purified as de- 
scribed  under  "Experimental Procedures." The  final column was  a Su- 
perose-12 10/30 gel filtration  column.  Protein  samples from each  frac- 
tion  were  either  assayed for Cdc25C-associating  kinase  activity (panel 
A )  or resolved on an 11% SDS-polyacrylamide gel and visualized by 
silver staining (panel B ) .  Molecular mass standards for the Super- 
ose-12 10/30 column were  run  under  the  same  conditions  used for the 
purification (bovine serum albumin, 66 kDa; carbonic anhydrase, 29 
kDa; cytochrome c, 12.4  kDa). Two proteins  that copurify with Cdc25C- 
associating  kinase  activity  are  indicated by A and B. 
initial  trigger  that  facilitates  the  interaction between Cdc25C 
and  inactive Cdc2-cyclin B. 
Serine 214 was  among  the  sites  reported  to be phosphoryl- 
ated by Cdc2-cyclin B i n  vitro (44).  Based on the  migration of 
tryptic phosphopeptides, Strausfeld et al. (44) proposed that 
serine 214 is  also phosphorylated in mitotic human  nontrans- 
formed fibroblasts (HS-268).  Both serine 214 and  serine 216 are 
present  within  the  same  tryptic phosphopeptide, and  it  is  un- 
clear  whether  the  researchers were able  to  distinguish  peptides 
phosphorylated on serine 214 from those phosphorylated on 
serine 216. Under  the  experimental conditions employed in  this 
study, we were able  to  distinguish  these phosphopeptides and 
were able  to identify serine 216 as  the major site of Cdc25C 
phosphorylation in asynchronously  growing  HeLa cells (Fig. 3). 
With  this  added knowledge, it will be important  to  determine 
whether serine 214, serine 216, or both are phosphorylated 
during M-phase and,  in  addition,  whether  the phosphorylation 
of one site effects phosphorylation of the other. 
Some studies  suggest  that  there  is a mechanism for activa- 
tion of Cdc25 proteins that is independent from Cdk-cyclin 
complexes. Treatment of Xenopus interphase  extracts  with  the 
phosphatase  inhibitor, okadaic  acid, causes  premature activa- 
tion of Cdc2 (50,51).  In  this  system, Cdc25 becomes hyperphos- 
phorylated and  activated  prior to activation of cyclin A- and 
cyclin B-associated H1 kinase activities and  nuclear envelope 
breakdown (35). These  data  suggest  that a mechanism other 
than phosphorylation of Cdc25 by Cdc2-cyclin complexes is re- 
sponsible for facilitating  the  initial  interaction between Cdc2- 
cyclin B and Cdc25. Due to  the poor enzymatic activity of re- 
combinant Cdc25C and the limited quantities of available 
purified Cdc25C-associating kinase, we have been unable to 
adequately  address  whether phosphorylation at serine 216 ef- 
fects the enzymatic activity of human Cdc25C. This will be 
more  easily addressed once a recombinant source of the  kinase 
is available. 
Increased  phosphatase activity of Cdc25 may not be suffi- 
cient  to  cause  the activation of Cdc2-cyclin B. Microinjection of 
Cdc25C that  has been  phosphorylated by Cdc2-cyclin B in vitro 
into G,-phase mammalian  tissue  culture cells causes a prema- 
ture prophase-like  phenotype (44). Phosphorylated Cdc25C is 
2-3 times more  active i n  vitro than  unphosphorylated Cdc25C, 
but microinjection of 10  times more unphosphorylated Cdc25C 
protein  has no effect in  vivo. Thus,  under  these  experimental 
conditions, phosphatase activity alone is insufficient for the 
activation of Cdc2-cyclin B by Cdc25C in vivo. One  possibility to  
explain  these  results would be if unphosphorylated Cdc25C is 
sequestered  away from Cdc2-cyclin B, whereas phosphorylated 
Cdc25C localizes differently and  is  able  to  interact  with Cdc2- 
cyclin B. Consistent with this hypothesis is the observation 
that microinjected phosphorylated Cdc25C does not accumu- 
late in the nucleus as readily as unphosphorylated Cdc25C 
(44).  Therefore, the subcellular compartmentalization of 
Cdc25C may significantly contribute  to  the  regulation of its 
substrate  interactions. 
We have purified a serine  kinase that specifically binds to the 
region  bordered by amino acids 200-256  of human Cdc25C that 
is lacking  in  hamster Cdc25C. This region is sufficient for bind- 
ing the Cdc25C-associating kinase and, in addition, may be 
necessary since hamster Cdc25C is  unable  to bind to  the ki- 
nase.  Human Cdc25A and Cdc25B proteins contain a region 
corresponding to  amino acids 200-256 of human Cdc25C, and 
all  three bind to  a kinase activity that will phosphorylate a 
serine 216 containing ~ e p t i d e . ~   I t  remains  to be determined if 
all  three  human Cdc25 proteins  interact  with  distinct Cdc25- 
associating  kinases. 
It  is  important  to  note  that  the  interactions we have exam- 
ined between Cdc25C and  the associating kinase  have been in  
vitro. We have  not directly demonstrated  that Cdc25C stably 
associates  with  the  serine 216 kinase i n  vivo. Studies  are cur- 
rently  underway  to directly address  this  question.  In addition, 
studies  are  currently  underway  to  determine  whether  the pu- 
tative  bipartite  nuclear localization signal of Cdc25C functions 
as an  authentic  nuclear localization signal i n  vivo. However, 
given that  the  associating  kinase phosphorylates Cdc25C on 
the major site of phosphorylation  detected in vivo and  binds  to 
a  region  conserved in  other Cdc25 family  members, we purified 
the activity from rat  liver. The purification of the Cdc25C- 
associating  kinase identified  two proteins with apparent mo- 
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TARLE I 
Purification of Cdc25C-associating  kinase  activity  from  rat  liver 
Step activity 
Total Protein Specific activity Purification Yield 
units  mg  unitslmg -fold % 
100.000 x g supernatant 12900 7500 1.7 1 100 
S-Sepharose  5726  62  92  54  44 
Q-Sepharose  1465  3.3  440 260 11 
ATP-agarose  1012 0.66" 1500 880 7.8 
Resource S 453 0.17" 2700 1600  3.5 
Superose-12 427 0.03" 14000  8200 3.3 
Estimated from A,,, nm tracing. 
A 
GST-25 s ( 2 0 0 - 2 5 6 ) s  z 
2 1  2 1 2 2  15 c( 
-200 kDa- 
B 
(200-256) ? GST-25 
1 2 1 2 -  15 
- 1 0 0  kDa- 
-68 kDa- 
4 3  kDa. 
-28 kDa. 
FIG. 8. Rat liver Cdc25C-associating kinase purifies as a 36-38- 
kDa doublet. Fractions 17-19 from the Superose-12  10/30  column  (see 
Fig.  7)  were pooled. A  portion of the pooled fractions  was collected into 
sample buffer (outside lanes). Either buffer only (lanes I )  or pooled 
fractions (lanes 2 )  were  incubated  with GST or GST-25(200-256) im- 
mobilized on GSH-agarose  beads.  After  washing,  proteins  were  solubi- 
lized with SDS sample  buffer  and boiling. A  portion of each  sample  was 
resolved on an 11% SDS-polyacrylamide gel and visualized by silver 
staining (panel A). Another  portion  was resolved on an 11% SDS-poly- 
acrylamide gel that had been polymerized in the presence of GST- 
25(200-256). Protein  samples  were resolved on the gel  and  subjected  to 
a denaturatiodrenaturation protocol followed  by an  in  gel  kinase  assay. 
Kinase  activity  was  visualized by autoradiography (panel B). Two pro- 
teins  that copurify with Cdc25C-associating kinase activity are indi- 
cated by A and B. 
lecular  masses of 36-38 kDa. A characteristic of the purified 
kinase activity is  that  it  phosphorylated a peptide correspond- 
ing to amino acids 210-231 of human Cdc25C but not the 
equivalent peptide in which serine 216 had been changed to a 
t h re~n ine .~ .  CAMP-dependent protein kinase  shared  this  char- 
acteristic,  but  the purified Cdc25C-associating kinase activity 
was not  inhibited by PKI,  a specific inhibitor of CAMP-depend- 
ent protein k i n a ~ e . ~  Calciudcalmodulin-dependent  kinase I1 
and protein kinase  Ca were distinguished from the purified 
kinase because they phosphorylated both serine  and  threonine 
a t  position 216 in  the context of the ~ e p t i d e . ~  Cdc2-cyclin B can 
serine 214 but  not  serine 216. It will be important  to identify 
the Cdc25C-associating kinase  and  to  characterize  its  interac- 
tions  with Cdc25C throughout  the cell  cycle. 
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